Evaluation of toll-like receptor 4 polymorphism in patients with hepatitis c virus-induced hepatocellular carcinoma | ||
| Egyptian Journal of Medical Microbiology | ||
| Article 1, Volume 30, Issue 3, July 2021, Pages 1-8 PDF (332.49 K) | ||
| Document Type: New and original researches in the field of Microbiology. | ||
| Author | ||
| Fatma Omar Khalil* | ||
| Assistant Professor of Clinical Microbiology and Immunology Department – National Liver Institute- Menoufia University, Menoufia Egypt | ||
| Abstract | ||
| Background: Liver related pathologies including Hepatocellular Carcinoma (HCC) is a universal problem. Innate immunity receptorswere accused in the etiopathogenesis of HCC with many conflicts. TLR4 is one of pathogen recognition receptors involved in the pathogenesis of many diseases and malignancies. TLR4 receptor polymorphisms were investigated in HCV related morbidities along with inconclusive results Objectives: to study the role of TLR4 rs 2149356 and rs 1927914 genotypes polymorphisms in HCV related HCC development. Methodology: 200 Chronically infected HCV patients were enrolled in this study. they were divided according to lab and clinical data into 100 CHCgroup and 100 HCC patients who were compared to health individual. The blood samples obtained were further proceed to full lab and TLR4 genotyping byRFLP-PCRtechnique Results: GT genotype and T allele of TLR4 rs 2149356 at 95% CI of 0.38 (0.21-0.70) was significantly increased in control group than in HCC and CHC groups. At 0.32(0.17-0.63)TLR4 rs 1927914 C allele and CT genotype was significantly increased in Controls than diseased groups while T allele is significantly increased in HCC than control group. Conclusions: TLR4 genotypes may play a protective role against HCC development among chronic HCV patients. | ||
| Keywords | ||
| TLR4 polymorphism; HCV; HCC; RFLP | ||
|
Statistics Article View: 184 PDF Download: 163 |
||
